Covidence #,Study ID,Title,Reviewer Name,Study ID,Title,Date of publication,Lead author contact details,Link to publication,Notes,How many different databases does the study use?,Database 1: Which country/countries are the clinical data from? ,"Database 1: If the routinely collected data / cohort are explicitly named, please provide the name(s). ","Database 1: If available, link the database / cohort.",Database 1: What kind of data does the database contain (multiple choice): ,Database 1: Are the data publicly available?,Database 1: Is the data collection still ongoing?,Database 2: Which country/countries are the clinical data from? ,"Database 2: If the routinely collected data / cohort are explicitly named, please provide the name(s). ","Database 2: If available, link the database / cohort.",Database 2: What kind of data does the database contain (multiple choice): ,Database 2: Are the data publicly available?,Database 2: Is the data collection still ongoing?,Database 3: Which country/countries are the clinical data from? ,"Database 3: If the routinely collected data / cohort are explicitly named, please provide the name(s). ","Database 3: If available, link the database / cohort.",Database 3: What kind of data does the database contain (multiple choice): ,Database 3: Are the data publicly available?,Database 3: Is the data collection still ongoing?,Database 4: Which country/countries are the clinical data from? ,"Database 4: If the routinely collected data / cohort are explicitly named, please provide the name(s). ","Database 4: If available, link the database / cohort.",Database 4: What kind of data does the database contain (multiple choice): ,Database 4: Are the data publicly available?,Database 4: Is the data collection still ongoing?
1108,Sibila 2012,Prior cardiovascular disease is associated with increased short and long-term mortality in COPD patients with community-acquired pneumonia,Consensus,#1108 – Sibila 2012,Prior Cardiovascular Disease Is Associated With Increased Short And Long-Term Mortality In COPD Patients With Community-Acquired Pneumonia,18.04.2013,"Marcos I. Restrepo, VERDICT (11C6), South Texas Veterans Health Care System ALMD, 7400 Merton Minter Boulevard, San Antonio, TX, 78229, USA. E-mail: restrepom@uthscsa.edu",https://erj.ersjournals.com/content/43/1/36.long,"17,140 elderly patients over 65y with 1 year outpatient treatment (assumedly for COPD) prior to admission for pneumonia",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","","","","","","","","","","","","","","","","","","","","",""
1097,Rothberg 2015,Dualtherapy for pseudomonas and outcomes in healthcare associated pneumonia,Consensus,#1097 – Rothberg 2015,Dual therapy for pseudomonas and outcomes in healthcare associated pneumonia,14.04.2015,"Department of Medicine, Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Tel: +1-216-445-6600; E-mail: rothbem@ccf.org",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405523/,"",1,"",Premier Healthcare Database,"","","","","","","","","","","","","","","","","","","","","",""
1096,Rothberg 2015,Oral versus intravenous fluoroquinolones for the initial treatment of community acquired pneumonia in hospitalized patients,Consensus,#1096 – Rothberg 2015,Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia,05.04.2016,"R. K. Belforti, Baystate Medical Center, 759 Chestnut St, Springfield, MA 01199 (raquel.belforti@bhs.org)",https://academic.oup.com/cid/article/63/1/1/1745398,"",1,"",Premier Healthcare Database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
1046,Lodise 2019,Antimicrobial resistance or delayed appropriate therapy - Does one influence outcomes more than the other among patients with serious infections due to carbapenem-resistant versus carbapenem-susceptible enterobacteriaceae?,Consensus,#1046 – Lodise 2019,"Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible 
Enterobacteriaceae?",23.04.2019,"Thomas P. Lodise, PharmD, PhD, Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave., Albany, NY 12208 (thomas.lodise@acphs.edu)",https://academic.oup.com/ofid/article/6/6/ofz194/5477302?login=false,"",1,"",Premier Healthcare Database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
1042,Wu 2019,Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score,Consensus,#1042 – Wu 2019,Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score,05.11.2019,"Yi Chen, Department of Emergency Medicine, South Campus, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 2000, 
Jiangyue Road, Minhang District, Shanghai 201112, China chenyirenji@126.com",https://pubmed.ncbi.nlm.nih.gov/31723357/,"",1,Other: China,Emergency-Rheum,NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
1038,Bonine 2019,Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections,Consensus,#1038 – Bonine 2019,Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections,22.11.2018,"Nicole G. Bonine, PhD, MPH, Global Health Outcomes Strategy & Research, Allergan plc, 2525 Dupont Drive (T2-2P), Irvine, CA 92612-1599. (E-mail: nicole.bonine@allergan.com).",https://pubmed.ncbi.nlm.nih.gov/30665490/,"",1,USA,Premier Healthcare Database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
984,Cao 2021,High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China,Consensus,#984 – Cao 2021,High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China,19.02.2021,"Taisheng Li
litsh@263.net",https://pubmed.ncbi.nlm.nih.gov/33679771/,Corrigendum: https://pubmed.ncbi.nlm.nih.gov/33831136/,1,Other: China,Two University Hospitals in Wuhan Region,NI,Hospital data (electronic health record),No,NI,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
971,Okuno 2021,Impact of corticosteroid administration within 7 days of the hospitalization for influenza pneumonia with respiratory failure: A propensity score analysis using a nationwide administrative database,Consensus,#971 – Okuno 2021,Impact of corticosteroid administration within 7 days of the hospitalization for influenza pneumonia with respiratory failure: A propensity score analysis using a nationwide administrative database,31.01.2021,"Takashi Kido
ido@nagasaki-u.ac.jp; Tel.: +81-95-819-7273",https://pubmed.ncbi.nlm.nih.gov/33572558/,"",1,Japan,Diagnosis Procedure Combination database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
969,Ferdinands 2021,"Vaccine Effectiveness against Influenza-Associated Hospitalizations among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network",Consensus,#969 – Ferdinands 2021,"Vaccine Effectiveness against Influenza-Associated Hospitalizations among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network",18.12.2020," Jill M. Ferdinands, PhD, Centers for Disease Control and Prevention, 1600 
Clifton Rd NE, MS A-32, Atlanta, GA 30333, USA (jferdinands@cdc.gov).",https://doi.org/10.1093/infdis/jiaa772,"This looks like the successor:
https://www.cdc.gov/flu/vaccines-work/ivy.htm",1,USA,Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN),https://www.cdc.gov/flu/vaccines-work/haiven.html,Hospital data (electronic health record),No,No,"","","","","","","","","","","","","","","","","",""
962,Patchen 2021,Genetically predicted serum vitamin D and COVID-19: A Mendelian randomisation study,Consensus,#962 – Patchen 2021,Genetically predicted serum vitamin D and COVID-19: A Mendelian randomisation study,04.05.2021,"Dr Patricia A Cassano, Division 
of Nutritional Sciences, Cornell 
University, Ithaca, NY 14853, 
USA; pac6@cornell.edu",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098235/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
939,Imai 2022,Economic and clinical burden from carbapenem-resistant bacterial infections and factors contributing: a retrospective study using electronic medical records in Japan,Consensus,#939 – Imai 2022,Economic and clinical burden from carbapenem-resistant bacterial infections and factors contributing: a retrospective study using electronic medical records in Japan,29.06.2022,"Norihiko Inoue, I think... (doesn't say for sure) noricom.tmdu@gmail.com",https://pubmed.ncbi.nlm.nih.gov/35768778/,"Interested researchers can contact (700-
dbproject@mail.hosp.go.jp) the NHO database division to
obtain more information about the NHO database for
utilization.",1,Japan,National Hospital Organization (NHO) Japan database,https://pubmed.ncbi.nlm.nih.gov/35615723/,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
927,Zha 2022,Pragmatic Comparison of Piperacillin/Tazobactam versus Carbapenems in Treating Patients with Nosocomial Pneumonia Caused by Extended-Spectrum beta-Lactamase-Producing Klebsiella pneumoniae,Consensus,#927 – Zha 2022,Pragmatic Comparison of Piperacillin/Tazobactam versus Carbapenems in Treating Patients with Nosocomial Pneumonia Caused by Extended-Spectrum beta-Lactamase-Producing Klebsiella pneumoniae,10.10.2022,Lei Zha - lei.zha@liverpool.ac.uk; Boris Tefzen - boris.tefsen@ronininstitute.org,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598608/,"retrospective, two hospitals in Wuhu (China). ",1,Other: China,NI,NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
902,Wozniak 2022,"Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia",Consensus,#902 – Wozniak 2022,"Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia",07.07.2022,"Principal Research Scientist, Australian e-Health Research Centre CSIRO, Level 7, 296 Herston Road, Herston Qld 4029, Australia. E-mail address: teresa.wozniak@csiro.au (Teresa Wozniak)",https://doi.org/10.1016/j.lanwpc.2022.100521,"This study is not relevant. No in-hospital data, actually a prediction model. Exclude.",1,Other: Australia,Health and Economic Modelling of AMR in Australia (HEMAA) population-level simulation model ,NI,"Other: ""Population-level simulation model""",NI,NI,"","","","","","","","","","","","","","","","","",""
434,Bordon 2008,The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.,Consensus,#434 – Bordon 2008,The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.,15.01.2008,"Correspondence to: José Bordón, MD, PhD, Providence Hospital, Department of Medicine, Section of Infectious Diseases, 1150 Varnum St, NE, Washington, DC 20017
bordonjose@yahoo.com [undefined:bordonjose@yahoo.com]",https://doi.org/10.1378/chest.07-1322,Data collection stopped 2006.,1,"Other: Not stated, but ""12 countries""",Community-Acquired Pneumonia Organization (CAPO) International Cohort study,NI,Hospital data (electronic health record),No,No,"","","","","","","","","","","","","","","","","",""
423,Liu 2012,Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.,Consensus,#423 – Liu 2012,Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.,15.12.2012,"Correspondence to Mei-Shu Lai, Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 5Fl. No. 17, Hsu Chow Road, Taipei 100, Taiwan.Tel: +886 2 33668028; fax: +886 2 23511955; e-mail: mslai@ntu.edu.tw",https://doi.org/10.1097/hjh.0b013e328357a87a,On site analysis through Virtual Desktop,1,Other: Taiwan,National Health Insurance Research Database (NHIRD),"https://nhird.nhri.edu.tw/date_01_en.html
https://www.dovepress.com/taiwans-national-health-insurance-research-database-past-and-future-peer-reviewed-fulltext-article-CLEP",Insurance/claims data (prescription data),No,Yes,"","","","","","","","","","","","","","","","","",""
418,Sibila 2014,Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.,Consensus,#418 – Sibila 2014,Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.,18.04.2013,"M.I. Restrepo, VERDICT (11C6), South Texas Veterans Health Care System ALMD, 7400 Merton Minter Boulevard, San Antonio, TX, 78229, USA. E-mail: restrepom@uthscsa.edu",https://pubmed.ncbi.nlm.nih.gov/23598950/,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
417,Tagami 2014,Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.,Consensus,#417 – Tagami 2014,Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.,23.06.2014,"Takashi Tagami, Department of Clinical Epidemiology and Health Economics, School of Public Health, Graduate School of Medicine, University of Tokyo, 7‐3‐1 Hongo, Bunkyo‐ku, Tokyo 1138555, Japan.Tel.: +81 358411887; fax: +81 358411888.E‐mail:
t-tagami@nms.ac.jp",https://doi.org/10.1111/jth.12643,"",1,Japan,Diagnosis Procedure Combination database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
396,Inoue 2019,Adjunctive Corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia.,Consensus,#396 – Inoue 2019,"Adjunctive Corticosteroids decreased the risk of mortality of
non-HIV Pneumocystis Pneumonia",02.12.2018,"Kiyohide Fushimi

Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization Headquarters, 2-5-21, Higashigaoka, Meguro-Ku, 152-8621, Tokyo, Japan. Electronic address: kfushimi.hci@tmd.ac.jp.",https://pubmed.ncbi.nlm.nih.gov/30529109/,"",1,Japan,Diagnosis Procedure Combination database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
395,Tartof 2019,Safety of Influenza Vaccination Administered During Hospitalization.,Consensus,#395 – Tartof 2019,Safety of Influenza Vaccination Administered During Hospitalization.,08.01.2019,"Sara Y. Tartof, PhD, MPH, Department of Research and Evaluation, Kaiser Permanente Southern California, 100 S Los Robles, 2nd Floor, Pasadena, CA 91101 (sara.y.tartof@kp.org)",https://pubmed.ncbi.nlm.nih.gov/30635116/,"",1,USA,KPSC,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
394,Webb 2019,Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study.,Consensus,#394 – Webb 2019,Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study.,04.07.2019,"Brandon J. Webb, Division of Infectious Diseases and Clinical Epidemiology, Intermountain Medical Center, 5121 South Cottonwood Drive, Murray, UT 84157, USA. E-mail: brandon.webb@imail.org",https://doi.org/10.1183/13993003.00057-2019,"",1,USA,enterprise data warehouse (EDW) at Intermountain Healthcare,NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
392,Webb 2019,Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.,Consensus,#392 – Webb 2019,Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.,08.05.2019,"Brandon J. Webb, MD, Division of Infectious Diseases and Clinical Epidemiology, Intermountain Medical Center, 5121 S Cottonwood Dr, Murray, UT 84157",https://doi.org/10.1016/j.chest.2019.04.093,"",1,USA,enterprise data warehouse (EDW) at Intermountain Healthcare,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
391,Suzuki 2019,Azithromycin plus beta-lactam versus levofloxacin plus beta-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis.,Consensus,#391 – Suzuki 2019,Azithromycin plus beta-lactam versus levofloxacin plus beta-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis.,19.06.2019,"Corresponding author. Division of Infectious Diseases, Jichi Medical University Hospital, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan. E-mail addresses: j-suzuki@jichi.ac.jp (J. Suzuki), sasabuchi-tky@umin.ac.jp (Y. Sasabuchi), shatake-tky@umin.ac.jp (S. Hatakeyama), ptmatsui-tky@umin.ac.jp (H. Matsui), protozoa@jichi.ac.jp (T. Sasahara), yujim@jichi.ac.jp (Y. Morisawa), yamadanji@jichi.ac.jp (T. Yamada), yasunagah-tky@umin.ac.jp (H. Yasunaga).",https://pubmed.ncbi.nlm.nih.gov/31227381/,"",1,Japan,Diagnosis Procedure Combination database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
381,Silva 2020,Mortality Trends for Veterans Hospitalized With Heart Failure and Pneumonia Using Claims-Based vs Clinical Risk-Adjustment Variables.,Consensus,#381 – Silva 2020,Mortality Trends for Veterans Hospitalized With Heart Failure and Pneumonia Using Claims-Based vs Clinical Risk-Adjustment Variables.,20.12.2019,"Amal N. Trivedi, MD, MPH, 121 S Main St, 7th Floor, Providence, RI 02903
(amal_trivedi@brown.edu).","https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2757530#:~:text=Unadjusted%2030%2Dday%20mortality%20rates,CI%2C%200.043%20to%200.063%5D).","",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
379,Jones 2020,Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.,Consensus,#379 – Jones 2020,Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.,17.02.2020,"Barbara
Ellen Jones, MD, MSc, Division of
Pulmonary and Critical Care, Veterans
Affairs Salt Lake City Health Care
System, 50 N Medical Dr,
Wintrobe 701, Salt Lake City, UT
84132 (barbara.jones@hsc.utah.edu)",https://pubmed.ncbi.nlm.nih.gov/32065604/,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
374,Ayerbe 2020,The association between treatment with heparin and survival in patients with Covid-19.,Consensus,#374 – Ayerbe 2020,The association between treatment with heparin and survival in patients with Covid-19.,31.03.2020,"Luis Ayerbe 
l.garcia-morzon@qmul.ac.uk
Centre of Primary Care and Public Health, Queen Mary 
University of London, 58 Turner Street, London E1 2AB, 
UK",https://doi.org/10.1007/s11239-020-02162-z,"",1,Spain,HM Hospitales,"https://www.internationalhm.com/en/investigation/investigation-lines

https://www.hmhospitales.com/SiteAssets/coronavirus/covid-data-save-lives/english-version/Aplication_for_acces_to_Dataset_V3%2520-%2520English.docx&ved=2ahUKEwj4mPa-1qiFAxWcEhAIHVK6C5cQFnoECBIQAQ&usg=AOvVaw3UYA7T8wISBeLQPSGy2Ioz",Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
370,Zhang 2020,In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.,Consensus,#370 – Zhang 2020,In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.,24 Jun 2020,"jihong.xia@hust.edu.cn (J.X.), yibinwang@mednet.ucla.edu (Y.W.), caijingjing83@hotmail.com (J.C.), guoj@gdpu.edu.cn (J.G.), lihl@whu.edu.cn (H.L.)",https://doi.org/10.1016/j.cmet.2020.06.015,Hospital data abstracted into study database until 2020. ,1,Other: China,NI,NI,Hospital data (electronic health record),No,No,"","","","","","","","","","","","","","","","","",""
369,Althoff 2020,Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations.,Consensus,#369 – Althoff 2020,"Noninvasive Ventilation Use in Critically Ill Patients with Acute
Asthma Exacerbations",01.12.2020,"Meghan D. Althoff, M.D., Ph.D., Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, 12700 East 19th Avenue, RM 9023, Mail Stop C272, Aurora, CO 80045. E-mail: meghan.althoff@cuanschutz.edu",https://pubmed.ncbi.nlm.nih.gov/32663410/,"",1,USA,Premier Healthcare Database,https://offers.premierinc.com/rs/381-NBB-525/images/PremierHealthcareDatabaseWhitepaper.pdf,Insurance/claims data (prescription data),No,Yes,"","","","","","","","","","","","","","","","","",""
367,Kalligeros 2020,Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.,Consensus,#367 – Kalligeros 2020,Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.,05.08.2020,"Cheston Cunha - ccunha@Lifespan.org, Eleftherios Mylonakis - emylonakis@lifespan.org",https://pubmed.ncbi.nlm.nih.gov/32763357/,"",1,USA,Rhode Island Hospital,NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
365,Anonymous 2020,Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study.,Consensus,#365 - Anonymous,Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study,25.08.2020,"Licia Iacoviello, Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell’Elettronica, 86077 Pozzilli (IS), Italy. licia.iacoviello@moli-sani.org ",https://doi.org/10.1016/j.ejim.2020.08.019,"",1,Other: Italy,CORIST Collaboration,NI,"",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
361,Liu 2020,Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.,Consensus,#361 – Liu 2020,Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.,03.11.2020,"Dechang Chen or Jieming Qu, no. 197, Ruijin 2nd Road, Shanghai 200025, China. Email: chendechangsh@hotmail.com (DC) or jmqu0906@163.com (JQ). 

Or to: Djillali Annane, Department of Intensive Care, Hôpital Raymond Poincaré (APHP), Laboratory of Infection & Inflammation — U1173, School of Medicine Simone Veil, University Versailles Saint Quentin — University Paris Saclay, INSERM, Garches 92380, France. Email: djillali.annane@aphp.fr.",https://pubmed.ncbi.nlm.nih.gov/33141117/,"",1,Other: China,NI,NI,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
358,Nachega 2020,Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo.,Consensus,#358 – Nachega 2020,Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo.,02.10.2020,"Address correspondence to Jean B. Nachega, Department of Epidemiology, Infectious Diseases and Microbiology, Center for Global Health, University of Pittsburgh Graduate School of Public Health, 130 DeSoto St., Crabtree Hall A531, Pittsburgh, PA 15261. E-mail: jbn16@pitt.edu",https://doi.org/10.4269/ajtmh.20-1240,"",1,Other: Democratic Republic Congo,DRC Ministry of Health’s COVID-19 Multi-Sectoral Response Committee database,NI,"Hospital data (electronic health record); National registries (e.g. death registry, cancer registry, etc.)",NI,NI,"","","","","","","","","","","","","","","","","",""
356,Geleris 2020,Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.,Consensus,#356 – Geleris 2020,Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19,07.05.2020,"Dr. Schluger at the Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, PH-8 E., Rm. 101, 622 W. 168th St., New York, NY 10032, or at ns311@cumc.columbia.edu.",https://www.nejm.org/doi/full/10.1056/nejmoa2012410,"",1,USA,New York-Presbytarian Columbia University Irving Medical Center (CUIMC),NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
355,Mahevas 2020,Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.,Consensus,#355 – Mahevas 2020,Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.,14.05.2020,"M Mahévas, matthieu.mahevas@gmail.com (ORCID 0000-0001-9182-1434)",https://pubmed.ncbi.nlm.nih.gov/32409486/,"",1,France,NI,NI,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
353,Ayerbe 2020,The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.,Consensus,#353 – Ayerbe 2020,The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.,03.09.2020,"Luis Ayerbe 
l.garcia-morzon@qmul.ac.u",https://doi.org/10.1007/s11739-020-02505-x,"",1,Spain,HM Hospitales,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
351,Jeong 2021,Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study.,Consensus,#351 – Jeong 2021,Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study,27.07.2020,"Ju-Young Shin, School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do 16419, South Korea; Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, 81 Irwon-ro, Gangnam-gu, Seoul 06351, 
South Korea (shin.jy@skku.edu)",https://academic.oup.com/cid/article/73/11/e4179/5876905,"",1,"",Health Insurance Review and Assessment Service (HIRA) database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
350,Rodriguez-Bano 2021,Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).,Consensus,#350 – Rodriguez-Bano 2021,Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).,27.08.2022,"Jesús Rodríguez-Bano, Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen Macarena, Avda Dr Fedriani 3, 41009 Seville. Spain. 
E-mail address: jesusrb@us.es (J. Rodríguez-Bano) ",https://doi.org/10.1016/j.cmi.2020.08.010,censoring date april 17 2020,1,Spain, COVID19@Spain cohort,https://classic.clinicaltrials.gov/ct2/show/NCT04355871,Hospital data (electronic health record),No,No,"","","","","","","","","","","","","","","","","",""
349,Bartoletti 2021,Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.,Consensus,#349 – Bartoletti 2021,Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.,22.09.2020,"Michele Bartoletti, Infectious Diseases Unit, Sant’Orsola Malpighi Hospital, Via Massarenti 11, 40137, Bologna, Italy.
E-mail address: m.bartoletti@unibo.it (M. Bartoletti).",https://doi.org/10.1016/j.cmi.2020.09.014,"",1,Other: Italy,PREDI-CO,https://clinicaltrials.gov/study/NCT04316949,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
348,Martinez-Sanz 2021,Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study.,Consensus,#348 – Martinez-Sanz 2021,Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study.,23.09.2020,"Javier Martínez-Sanz, Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá (IRYCIS), Carretera de Colmenar Viejo, Km 9.100, 28034, Madrid, Spain.
javier.martinez.sanz@salud.madrid.org",https://doi.org/10.1016/j.cmi.2020.09.021,"",1,Spain,HM Hospitales,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
347,Cariou 2021,Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.,Consensus,#347 – Cariou 2021,Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study,19.10.2020,"Bertrand Cariou, bertrand.cariou@univ-nantes.fr",https://doi.org/10.1016/j.diabet.2020.10.001,Only diabetic patients.,1,France,CORONADO Study,https://clinicaltrials.gov/study/NCT04324736?tab=table,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
345,Lafaurie 2021,Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study.,Consensus,#345 – Lafaurie 2021,Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study,28.10.2020,"Margaux Lafauriea
Service de Pharmacologie M edicale, Facult e de M edecine, Centre Hospitalier Universitaire de Toulouse, 37 allées Jules Guesde Toulouse 31000, France
margaux.lafaurie@univ-tlse3.fr",https://doi.org/10.1111/fcp.12613,"",1,France,Covid-Clinic-Toul cohort,https://www.sciencedirect.com/science/article/pii/S0248866320303490,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
342,Roumier 2021,Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.,Consensus,#342 – Roumier 2021,Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.,14.11.2020,"Félix Ackermann
f.ackermann@hopital-foch.com",https://pubmed.ncbi.nlm.nih.gov/33188624/,Probably also AP-HP DWH,1,France,NI,NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
340,Sinha 2021,The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.,Consensus,#340 – Sinha 2021,The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.,20.11.2020,"E. Y. Kissin, MD, 72 E. Newton St, E501, Boston, MA 02118 (eukissin@bu.edu)",https://pubmed.ncbi.nlm.nih.gov/33216906/,manually abstracted data from EHR into study database once. Not ongoing. Would drop.,1,USA,NI,NI,Hospital data (electronic health record),NI,No,"","","","","","","","","","","","","","","","","",""
337,Tran 2021,Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.,Consensus,#337 – Tran 2021,Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.,08.12.2020,"François-Xavier Lescure, Service de Maladies Infectieuses et Tropicales, Hopital Bichat, Assistance Publique Hopitaux de Paris
E-mail address: xavier.lescure@aphp.fr",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722522/,Physicians retrospectively performed patient by patient screening.,1,France; Other: Luxembourg,"REACTing (the network, not the database)",https://www.iame-research.center/associated-organisations/reacting-2/,Hospital data (electronic health record),No,No,"","","","","","","","","","","","","","","","","",""
334,Mendizabal 2021,Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.,Consensus,#334 – Mendizabal 2021,Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.,07.01.2021,mmendiza@cas.austral.edu.ar (M. Mendizabal),https://doi.org/10.1016/j.aohep.2020.100298,"",1,"Other: Latin America: Argentina, Brazil, Chile, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Paraguay, Peru, Uruguay",COVID-ALEH Registry,https://clinicaltrials.gov/study/NCT04358380,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
331,Andersen 2021,Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System.,Consensus,#331 – Andersen 2021,Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System,01.12.2021,"Correspondence: G. C. Alexander, Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, 615 N Wolfe Street, W6035, Baltimore, MD 21205 (galexan9@jhmi.edu).",https://doi.org/10.1093/cid/ciaa1488,"",1,USA, Johns Hopkins CROWN Registry,https://ictr.johnshopkins.edu/covid-research-center/review-committees/cadre/,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
329,DiCastelnuovo 2021,Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study.,Consensus,#329 – DiCastelnuovo 2021,Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study,07.01.2021,"Licia Iacoviello, MD, PhD, Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell’Elettronica, 86077 Pozzilli, Isernia, Italy (e-mail: licia.iacoviello@moli-sani.org)",https://doi.org/10.1055/a-1347-6070,"",1,Other: Italy,CORIST Collaboration,https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.15370,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
324,Roussel 2021,Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study.,Consensus,#324 – Roussel 2021,Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study,02.02.2021,"bertrand.cariou@univ-nantes.fr
Bertrand Cariou, Department of Endocrinology, Diabetology and Nutrition, l'institut du thorax, CHU Nantes, Hôpital Guillaume et René Laennec, 44093 Nantes Cedex 01, France",https://doi.org/10.1111/dom.14324,"",1,France,CORONADO Study,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
323,Hoertel 2021,Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study.,Consensus,#323 – Hoertel 2021,Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study,04.02.2021,"Nicolas Hoertel, nico.hoertel@yahoo.fr",https://doi.org/10.1038/s41380-021-01021-4,"",1,France,AP-HP Data Warehouse,https://eds.aphp.fr/nos-services/recherche-innovation,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
322,Rentsch 2021,Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study.,Consensus,#322 – Rentsch 2021,Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study.,11.02.2021,C T Rentsch christopher.rentsch@lshtm.ac.uk (or @darthctr on Twitter),https://www.bmj.com/content/372/bmj.n311,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
313,Lalau 2021,Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.,Consensus,#313 – Lalau 2021,"Metformin use is associated with a reduced risk of mortality in patients
with diabetes hospitalised for COVID-19",10.12.2020,"Lalau.Jean-Daniel@chu-amiens.fr (J.-D. Lalau), Al-Salameh.Abdallah@chu-amiens.fr (A. Al-Salameh)",https://doi.org/10.1016/j.diabet.2020.101216,"",1,France,CORONADO Study,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
310,deHavenon 2021,Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States.,Consensus,#310 – deHavenon 2021,Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States.,09.12.2020,"Department of Neurology, University of Utah, 175 N. Medical Dr, Salt Lake City, UT 84132, United States
adam.dehavenon@hsc.utah.edu",https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105535,"Requests from qualified researchers trained in human
subject confidentiality protocols to access the dataset
used in this study may be sent to Vizient at
vizientsupport@vizientinc.com.",1,USA,Vizient Clinical Data Base® (CDB),https://www.vizientinc.com/what-we-do/operations-and-quality/clinical-data-base,Insurance/claims data (prescription data),No,Yes,"","","","","","","","","","","","","","","","","",""
307,Hoertel 2021,Observational study of haloperidol in hospitalized patients with COVID-19.,Consensus,#307 – Hoertel 2021,"Observational study of haloperidol in
hospitalized patients with COVID-19",19.02.2021,"Marina Sanchez-Rico
De´partement de Psychiatrie, Hoˆpital Corentin-Celton, Centre Universite´ de Paris, AP-HP, Issy-les-
Moulineaux, France
marinals@ucm.es",https://doi.org/10.1371/journal.pone.0247122 ,"",1,France,AP-HP Data Warehouse,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
306,Hill 2021,"Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.",Consensus,#306 – Hill 2021,"Tocilizumab in hospitalized patients with COVID‐19: Clinical outcomes, inflammatory marker kinetics, and safety",17.11.2020,"Correspondence Joshua A. Hill, Fred Hutchinson Cancer Research Center and University of Washington, 1100 Fairview Ave N, Mail Stop E-400, Seattle, WA 98109.",https://onlinelibrary.wiley.com/doi/10.1002/jmv.26674,"",1,USA,University of Washington (UW) Enterprise Data Warehouse,https://itconnect.uw.edu/tools-services-support/data-reporting/data/enterprise-data-warehouse/,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
300,Pelton 2021,A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.,Consensus,#300 – Pelton 2021,A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.,30.03.2021,"Global Pricing & Health Economics Director, Seqirus Vaccines Ltd, 25 Deforest Avenue, Summit, NJ 07901, USA. Joaquin.Mould-Quevedo@seqirus.com",https://doi.org/10.1016/j.vaccine.2021.03.054,"",1,USA; Other: worldwide,IQVIA databases,https://www.iqvia.com/solutions/real-world-evidence/real-world-data-and-insights#HealthDataCatalog,Hospital data (electronic health record); Insurance/claims data (prescription data),No,Yes,"","","","","","","","","","","","","","","","","",""
299,Gallay 2021,Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study.,Consensus,"#299 - Gallay et al, 2021",Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study,02.04.2021,"Francois-Xavier Lescure, Service de maladies infectieuses et tropicales, Hopital Bichat, Assistance Publique Hopitaux de Paris, 75018, Paris, France. E-mail address: xavier.lescure@aphp.fr",https://doi.org/10.1016/j.cmi.2021.03.021,EHR abstracted into study database from 36 hospitals once. Very unclear from publication.,1,France,NI,NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
296,Gault 2021,Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.,Consensus,#296 – Gault 2021,Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.,20.04.2021,"Nathalie Gault, INSERM CIC-EC 1425, Hôpital Bichat, 46 rue Henri Huchard, 75018 Paris

Email: nathalie.gault@aphp.fr",https://doi.org/10.1111/fcp.12683,Available through Orchestra?,1,France,French COVID Cohort,"https://clinicaltrials.gov/study/NCT04262921
https://orchestra-cohort.eu/cohort-statistics/",Hospital data (electronic health record); Disease specific network (cohort study),Yes,Yes,"","","","","","","","","","","","","","","","","",""
287,Butler-Laporte 2021,Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.,Consensus,#287 – Butler-Laporte 2021,Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.,01.06.2021,brent.richards@mcgill.ca, https://doi.org/10.1371/journal.pmed.1003605,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
283,Vaughn 2021,Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.,Consensus,"#283 - Vaughn et al, 20021",Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19,11.06.2021,"Valerie M. Vaughn, MD, MSc, Assistant Professor of Medicine, Division of General Internal Medicine, University of Utah, 30 N 1900 E, Room 5R218, Salt Lake City, UT 84132 (ude.hatu.csh@nhguav.eirelav).",https://pubmed.ncbi.nlm.nih.gov/34115129/,"https://www.mi-hms.org/quality-initiatives/mi-covid19-
initiative-retired",1,USA,Mi-COVID19 Initiative,https://www.mi-hms.org/quality-initiatives/mi-covid19-initiative-retired,Hospital data (electronic health record),No,No,"","","","","","","","","","","","","","","","","",""
278,Cho 2021,Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial.,Consensus,#278 – Cho 2021,Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial.,21.06.2021," Kelly Cho, PhD, VA Boston Healthcare System, 150 S. Huntington Avenue, 
Boston, MA 02130 (Kelly.Cho@va.gov).",https://doi.org/10.1093/infdis/jiab330,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
277,Cui 2021,"Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study.",Consensus,#277 – Cui 2021,"Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study.",10.07.2021, tiany@bjmu.edu.cn,https://pubmed.ncbi.nlm.nih.gov/34246301/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
276,Recalde 2021,"Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.",Consensus,#276 – Recalde 2021,"Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom",15.07.2021,"Talita Duarte-Salles

Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
tduarte@idiapjgol.org",https://www.nature.com/articles/s41366-021-00893-4,"- Two other data sources:
-- Stanford Medicine Research Data Repository (STARR-OMOP) (http://arxiv.org/abs/2003.10534)
-- IQVIA Open Claims",Other: 6,Spain,System for Research in Primary Care (SIDIAP),NI,Hospital data (electronic health record); Other: Outpatient data,NI,NI,UK,Clinical Practice Research Datalink (CPRD),https://www.cprd.com/,Other: Outpatient,No,Yes,USA,New York-Presbyterian Columbia University Irving Medical Center (NYP-CUIMC) data warehouse,NI,Hospital data (electronic health record),NI,NI,USA,United States Department of Veterans Affairs (VA-OMOP),"",Hospital data (electronic health record),No,Yes
273,Zhu 2021,Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study.,Consensus,#273 – Zhu 2021,Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study.,06.08.2021,Dr Ying Bao; ying.bao@bms.com,https://bmjopen.bmj.com/content/11/8/e051588,"",1,Other: Global,TriNetX database,https://trinetx.com/solutions/real-world-datasets/#s_2,Hospital data (electronic health record); Other: Outpatient?,No,Yes,"","","","","","","","","","","","","","","","","",""
272,Hara 2021,Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.,Consensus,#272 – Hara 2021,Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan,10.09.2021,"Department of Cardiology, National Centre for Global Health and Medicine, 1-12-1 Toyama Shinjuku-ku, Tokyo 162-8655, Japan. Tel.: +81 3 3202 7181; fax: +81 3 3202 7364. E-mail address: hhara@hosp.ncgm.go.jp (H. Hara)",https://doi.org/10.1016/j.ijid.2021.09.014,Site translated with google translate. Looks like only participating sites can use data.,1,Japan,COVIREGI-JP,"https://rebind.ncgm.go.jp/coviregi/
https://academic.oup.com/cid/article/73/11/e3677/5912544",Hospital data (electronic health record); Disease specific network (cohort study),No,Yes,"","","","","","","","","","","","","","","","","",""
268,Baek 2021,COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea.,Consensus,#268 – Baek 2021,COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea.,01.10.2021,"Sun-Young JungI
* E-mail: jsyoung@cau.ac.kr
College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea, Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea",https://doi.org/10.1371/journal.pone.0257641,Can't find the publicaly released data.,1,South Korea,Health Insurance Review and Assessment Service (HIRA) database,hira-covid19.net is offline.,Insurance/claims data (prescription data),Yes,NI,"","","","","","","","","","","","","","","","","",""
264,Yoshikawa 2021,Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.,Consensus,#264 – Yoshikawa 2021,Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.,13.11.2021,"myosh-tky@umin.ac.jp
1 Division of Laboratory Medicine, Department of Pathology 
and Microbiology, Nihon University School of Medicine, Tokyo, Japan",https://pubmed.ncbi.nlm.nih.gov/34774031/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
263,Gervasi 2021,"Metabolic syndrome and risk of COVID-19-related hospitalization: a large, population-based cohort study carried out during the first European outbreak of SARS-CoV-2 infection in the Metropolitan area of Milan (Lombardy Region, Northern Italy).",Consensus,#263 – Gervasi 2021,"Metabolic syndrome and risk of COVID-19-related hospitalization: a large, population-based cohort study carried out during the first European outbreak of SARS-CoV-2 infection in the Metropolitan area of Milan (Lombardy Region, Northern Italy).",12.01.2022,Antonio Giampiero Russo; agrusso@ats-milano.it,https://pubmed.ncbi.nlm.nih.gov/34791868/,"Register on comobordities, but I don't think they have in
hospital data",1,Other: Italy,Agency for Health Protection (AHP) of Milan,NI,"National registries (e.g. death registry, cancer registry, etc.)",No,NI,"","","","","","","","","","","","","","","","","",""
259,Jian 2021,Genetically Predicted Higher Educational Attainment Decreases the Risk of COVID-19 Susceptibility and Severity: A Mendelian Randomization Study.,Consensus,#259 – Jian 2021,Genetically Predicted Higher Educational Attainment Decreases the Risk of COVID-19 Susceptibility and Severity: A Mendelian Randomization Study,23.12.2021,"Xin Wei
weixinscu@scu.edu.cn
Xi Jin
Jancy_king@hotmail.com",https://pubmed.ncbi.nlm.nih.gov/35004565/,"",1,"",See Covid 19 HGI,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
256,Bowe 2021,Kidney Outcomes in Long COVID.,Consensus,#256 – Bowe 2021,Kidney Outcomes in Long COVID.,15.11.2021," Dr. Ziyad Al-Aly, Veterans Affairs Saint Louis Health Care System, 915 North Grand Boulevard, 151-JC, Saint Louis, MO 63106. Email: zalaly@gmail.com", https://doi.org/10.1681/ASN.2021060734,"",1,USA,Department of Veterans Health Administration (VHA) healthcare system Data Warehouse,https://virec.research.va.gov/Non-VA-Researchers/Info_for_NonVA_Researchers.pdf,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
253,Pan 2021,"Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.",Consensus,#253 – Pan 2021,"Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.",21.12.2021,"Salim S. Hayek, MD, Division of Cardiology, Department of Medicine, University of Michigan Frankel Cardiovascular Center, 1500 E Medical Center Dr, CVC #2709, Ann Arbor, MI 48109. E‐mail: ude.hcimu.dem@keyahs",https://pubmed.ncbi.nlm.nih.gov/34889102/,"",1,Other: International,International Study of Inflammation in COVID‐19,"https://clinicaltrials.gov/study/NCT04818866

https://hayek.lab.medicine.umich.edu/research/covid19",Hospital data (electronic health record),NI,No,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
244,Kuno 2022,The association of hemoglobin drop with in-hospital outcomes in COVID-19 patients.,Consensus,#244 – Kuno 2022,The association of hemoglobin drop with in-hospital outcomes in COVID-19 patients.,01.10.2021,"Dr T. Kuno, MD, PhD, Division of Cardiology, Montefiore Medical Center, Albert Einsten College of Medicine, 111 East 210th St,
New York, 10467-2401, USA. email: tkuno@montefiore.org",doi.org/10.1093/qjmed/hcab251,"",1,USA,Mout Sinai Health System Data Warehouse,https://labs.icahn.mssm.edu/msdw/data-sources/,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
241,Tachiwada 2022,Effects of additive corticosteroid therapy on 90-day survival in patients with community-onset pneumonia.,Consensus,#241 – Tachiwada 2022,Effects of additive corticosteroid therapy on 90-day survival in patients with community-onset pneumonia.,23.12.2021,"E-mail addresses: tachiwada-t@med.uoeh-u.ac.jp (T. Tachiwada), sn0920@med.uoeh-u.ac.jp (S. Noguchi), km@med.uoeh-u.ac.jp (K. Muramatsu), kentarouakata@med.uoeh-u.ac.jp (K. Akata), yamasaki@med.uoeh-u.ac.jp (K. Yamasaki), t-asakawa@med.uoeh-u.ac.jp (T. Asakawa), zenq@med.uoeh-u.ac.jp (Y. Fujino), kfushimi.hci@tmd.ac.jp (K. Fushimi), smatsuda@med.uoeh-u.ac.jp (S. Matsuda), hmukae@nagasaki-u.ac.jp (H. Mukae), yatera@med.uoeh-u.ac.jp (K. Yatera)",https://doi.org/10.1016/j.jiac.2021.12.012,"",1,Japan,Diagnosis Procedure Combination database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
240,Sullerot 2022,Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia.,Consensus,#240 – Sullerot 2022,Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia.,07.01.2022,"Service de Médecine Interne Gériatrie, Hôpital de 
Champmaillot CHU, 21079 Dijon Cedex, France
e-mail: alain.putot@chu-dijon.fr
",https://doi.org/10.1007/s11357-021-00499-8,Manual abstraction from hospital data into study database,1,France; Other: Switzerland,NI,NI,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
233,Takahashi 2022,"Hospital factor and prognosis of COVID-19 in New York City, the United States of America: insights from a retrospective cohort study.",Consensus,#233 – Takahashi 2022,"Hospital factor and prognosis of COVID-19 in New York City, the United States of America: insights from a retrospective cohort study",08 Feb 2022,"Department of Cardiology, Montefiore Medical Center,
Albert Einstein Medical College, 111 East 210th St, Bronx, NY 10467–2401, USA.
E-mail address: kuno-toshiki@hotmail.co.jp",https://doi.org/10.1186/s12913-022-07570-w,"",1,USA,Mout Sinai Health System Data Warehouse,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
232,Xiong 2022,Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.,Consensus,#232 – Xiong 2022,Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.,17.05.2022,"Ian Chi Kei Wong

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

wongick@hku.hk",https://pubmed.ncbi.nlm.nih.gov/35216517/,"",1,Other: Hong Kong, Hong Kong Hospital Authority (HA),NI,"Hospital data (electronic health record); National registries (e.g. death registry, cancer registry, etc.)",No,NI,"","","","","","","","","","","","","","","","","",""
230,Huang 2022,Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality.,Consensus,#230 – Huang 2022,Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality.,08.03.2022,"Cheng-Wei Huang, MD, Department of Hospital Medicine, Kaiser Permanente Los Angeles Medical Center, 4867 W Sunset Blvd, 6th Flr, Los Angeles, CA 90027 (gro.pk@gnauh.iew-gnehc).",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905383/,"",1,USA,Kaiser Permanente Southern California (KPSC),"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
227,Xie 2022,Risks and burdens of incident diabetes in long COVID: a cohort study.,Consensus,#227 – Xie 2022,Risks and burdens of incident diabetes in long COVID: a cohort study.,21.03.2022,"Dr Ziyad Al-Aly, Clinical 
Epidemiology Center, and 
Development Service, 
VA Saint Louis Health Care 
System, Saint Louis, MO 63011, 
USA
ziyad.alaly@va.gov",https://doi.org/10.1016/S2213-8587(22)00044-4,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
224,Baranova 2022,Causal Association and Shared Genetics Between Asthma and COVID-19.,Consensus,#224 – Baranova 2022,"Causal Association and Shared
Genetics Between Asthma and
COVID-19",21.03.2022,"Fuquan Zhang
zhangfq@njmu.edu.cn",https://pubmed.ncbi.nlm.nih.gov/35386719/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
222,Qu 2022,Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients.,Consensus,#222 – Qu 2022,Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients.,29.01.2022,"Center for Applied Genomics, 3615 Civic Center Blvd, Abramson Building, Philadelphia, PA 19104, USA. hakonarson@email.chop.edu",https://doi.org/10.1016/j.metabol.2022.155156,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
219,Frohlich 2022,Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.,Consensus,#219 – Frohlich 2022,Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.,06.01.2022, Rami Sommerstein (rami.sommerstein@hirslanden.ch),https://pubmed.ncbi.nlm.nih.gov/34991775/,"Until December 31st 2023, the responsibility for ensuring
access to the data was held by the ISG, in accordance
with the provisions of a study protocol and a study
agreement signed by all participating entities and
approved by the Swissethics Comitees. From January 1
onward, the FOPH assumed this responsibility. Therefore,
any requests for data access should be sent directly to
them at the email address mt.data@bag.admin.ch.",1,Other: Switzerland,Hospital-based surveillance of COVID-19 and influenza cases in Switzerland,https://www.unige.ch/medecine/hospital-covid/,Hospital data (electronic health record),NI,Yes,"","","","","","","","","","","","","","","","","",""
217,Yang 2022,Genetic Landscape of the ACE2 Coronavirus Receptor.,Consensus,#217 – Yang 2022,Genetic Landscape of the ACE2 Coronavirus Receptor.,07.04.2022,"jim.wilson@ed.ac.uk
James F. Wilson, DPhil ",https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.121.057888,"",1,"",Covid 19 HGI,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
216,Kuno 2022,The association of statins use with survival of patients with COVID-19.,Consensus,#216 – Kuno 2022,The association of statins use with survival of patients with COVID-19.,22.12.2021,"Department of Cardiology, Montefiore Medical Center,
Albert Einstein Medical College, 111 East 210th St, Bronx, NY 10467–2401, USA.
E-mail address: tkuno@montefiore.org (T. Kuno)",https://doi.org/10.1016/j.jjcc.2021.12.012,"",1,USA,Mout Sinai Health System Data Warehouse,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
215,Kuno 2022,The association of anticoagulation before admission and survival of patients with COVID-19.,Consensus,#215 – Kuno 2022,The association of anticoagulation before admission and survival of patients with COVID-19.,16.12.2021,"Department of Cardiology, Montefiore Medical Center,
Albert Einstein Medical College, 111 East 210th St, Bronx, NY 10467–2401, USA.
E-mail address: tkuno@montefiore.org (T. Kuno)",https://doi.org/10.1016/j.jjcc.2021.12.007,"",1,USA,Mout Sinai Health System Data Warehouse,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
214,Chen 2022,"Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study.",Consensus,#214 – Chen 2022,"Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study.",24.02.2022,"Yanhong Gong, PhD, Department of Social Medicine and
Health Management, Tongji Medical College, Huazhong University of Sci-
ence and Technology, Wuhan 430030, P. R. China. Email: gongyanhong@
hust.edu.cn",https://linkinghub.elsevier.com/retrieve/pii/S1098301522000407,"",1,Other: China,"4 Hospitals in Hubei Province, China",NI,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
212,Battistoni 2022,Pre- and in-hospital anticoagulation therapy in coronavirus disease 2019 patients: a propensity-matched analysis of in-hospital outcomes.,Consensus,#212 – Battistoni 2022,Pre- and in-hospital anticoagulation therapy in coronavirus disease 2019 patients: a propensity-matched analysis of in-hospital outcomes.,01.04.2022,"laria Battistoni, MD, Azienda Ospedaliero-Universitaria ‘Ospedali Riuniti’, Dipartimento di Scienze Cardiovascolari, SOD Cardiologia e UTIC, Via Conca 71, 60100 Ancona, Italy E-mail: i.battistoni1982@gmail.com",https://journals.lww.com/jcardiovascularmedicine/fulltext/2022/04000/pre__and_in_hospital_anticoagulation_therapy_in.8.aspx,"Used a ""mcirosoft excel sheet model"". This is surely not useable.

Data collection ended July 2020.",1,Other: Europe,NI,NI,Hospital data (electronic health record),No,No,"","","","","","","","","","","","","","","","","",""
208,Hoertel 2022,Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study.,Consensus,#208 – Hoertel 2022,Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study,30.03.2022,"N. Hoertel,
E-mail: nico.hoertel@yahoo.fr;
nicolas.hoertel@aphp.fr",https://doi.org/10.1017/S2045796021000743,"",1,France,AP-HP Data Warehouse,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
206,Chow 2022,Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19.,Consensus,#206 – Chow 2022,Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19.,24.03.2022,"Jonathan H. Chow, MD, Department of Anesthesiology and Critical Care Medicine, George Washington University School of Medicine and Health Sciences, 2300 M St NW, Room 709, Washington, DC 20037 (jchow@mfa.gwu.edu).",https://doi.org/10.1001/jamanetworkopen.2022.3890,"",1,USA,National COVID Cohort Collaborative (N3C),"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
204,Memel 2022,Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.,Consensus,#204 – Memel 2022,Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.,19.10.2021,"Patricia P. Bloom, Division of Gastroenterology and Hepatology, Department 
of Internal Medicine, 1500 E Medical Center Dr, Ann Arbor, MI 48104 (ppbloom@med.umich.edu).",https://doi.org/10.1093/infdis/jiab539,"",1,USA,MGH Covid-19 Data Registry,https://rc.partners.org/about/projects-initiatives/new-covid-19-research-tools-researchers/covid-19-external-data-sets,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
202,Sobczyk 2022,"The Effect of Circulating Zinc, Selenium, Copper and Vitamin K1 on COVID-19 Outcomes: A Mendelian Randomization Study.",Consensus,#202 – Sobczyk 2022,"The Effect of Circulating Zinc, Selenium, Copper and Vitamin K1 on COVID-19 Outcomes: A Mendelian Randomization Study.",06.01.2022,"MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UK; 
maria.sobczyk@bristol.ac.uk",https://doi.org/10.3390/nu14020233,"",1,"",Covid HGI,"","",Other: ,Other: ,"",Avon Longitudinal Study of Parents and Children (ALSPAC),"","",Other: ,Other: ,"","","","","","","","","","","",""
201,Noh 2022,The prognostic role of anticoagulants in COVID-19 patients: national COVID-19 cohort in South Korea.,Consensus,#201 – Noh 2022,The prognostic role of anticoagulants in COVID-19 patients: national COVID-19 cohort in South Korea,01.04.2022,"Young-Geun Choi, Assistant Professor. Department of Statistics, Sookmyung Women’s University, 99 Cheongpa-Ro-47-Gil, Yongsan-Gu, Seoul 04310, South Korea. Email: ygchoi@sm.ac.kr.",https://dx.doi.org/10.21037/apm-21-3466,website down,1,South Korea,HIRA-Covid19,https://www.hira-covid19.net/,Insurance/claims data (prescription data),No,NI,"","","","","","","","","","","","","","","","","",""
200,Chow 2022,The association between statin and COVID-19 adverse outcomes: national COVID-19 cohort in South Korea.,Consensus,#200 – Chow 2022,The association between statin and COVID-19 adverse outcomes: national COVID-19 cohort in South Korea.,27.04.2022,"Young-Geun Choi, PhD. Assistant Professor, Department of Statistics, Sookmyung Women’s University, 99 Cheongpa-Ro-47-
Gil, Yongsan-Gu, Seoul 04310, South Korea. Email: ygchoi@sm.ac.kr",https://apm.amegroups.org/article/view/92106/html,"",1,"",Health Insurance Review and Assessment Service (HIRA) database,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
199,Shin 2022,The association between immunosuppressants use and COVID-19 adverse outcomes: national COVID-19 cohort in South Korea.,Consensus,#199 – Shin 2022,The association between immunosuppressants use and COVID-19 adverse outcomes: national COVID-19 cohort in South Korea.,27.04.2022,"Young-Geun Choi, Assistant Professor, PhD. Department of Statistics, Sookmyung Women’s University, Seoul 04310, South 
Korea. Email: ygchoi@sm.ac.kr. ",https://apm.amegroups.org/article/view/93037/html,"",1,"",Health Insurance Review and Assessment Service (HIRA) database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
195,Parks 2022,Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.,Consensus,#195 – Parks 2022,Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.,05.05.2022,"Anna Parks, anna.parks@hsc.utah.edu",https://doi.org/10.1371/journal.pone.0266944,"",1,USA,HOMERuN Network,https://hospitalinnovate.org/projects/completed-projects/,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
194,Yamamoto 2022,Early intubation and decreased in-hospital mortality in patients with coronavirus disease 2019.,Consensus,#194 – Yamamoto 2022,Early intubation and decreased in-hospital mortality in patients with coronavirus disease 2019.,06.05.2022,"ryo.yamamoto@gmail.com
Ryo Yamamoto
Department of Emergency and Critical Care Medicine, Keio University 
School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan",https://doi.org/10.1186/s13054-022-03995-1,"",1,Japan,J-RECOVER study group,https://www.jstage.jst.go.jp/article/ace/4/3/4_22012/_article,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
191,Sogaard 2022,Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy.,Consensus,#191 – Sogaard 2022,Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy,26.05.2022," Mette Søgaard, DVM, PhD, Department of Cardiology, Aalborg University Hospital, Sønder Skovvej 15, 9000 Aalborg, Denmark (mette.soegaard@rn.dk)",https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2792724,"National Patient Register has discharge diagnoses, unclear how much inpatient.",3,Denmark,Danish National Patient Register,"","Hospital data (electronic health record); National registries (e.g. death registry, cancer registry, etc.)",No,Yes,Denmark,The Civil Registration system,NI,"National registries (e.g. death registry, cancer registry, etc.)",No,Yes,Denmark,The Danish National Prescription Registry,https://pure.au.dk/portal/en/publications/the-danish-national-prescription-registry,Other: Outpatient prescriptions,No,Yes,"","","","","",""
185,Abelenda-Alonso 2022,Effect of positive microbiological testing on antibiotic de-escalation and outcomes in community-acquired pneumonia: a propensity score analysis.,Consensus,#185 – Abelenda-Alonso 2022,Effect of positive microbiological testing on antibiotic de-escalation and outcomes in community-acquired pneumonia: a propensity score analysis.,07.07.2022,"Gudiol, Hospital Universitari de Bellvitge, Department of Infectious Diseases, Hospital de Bellvitge, c/ Feixa Llarga s/n 08097, L'Hospitalet d’Llobregat, Barcelona, Spain.
cgudiol@bellvitgehospital.cat",https://pubmed.ncbi.nlm.nih.gov/35809784/,"",1,Spain,Bellvitge University Hospital Data Warehouse,NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
170,Cortellini 2022,Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.,Consensus,#170 – Cortellini 2022,Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.,30.11.2022,Dr Alessio Cortellini; alessiocortellini@gmail.com,https://jitc.bmj.com/content/10/11/e005732,"",2,Other: Europa wide,OnCovid,https://imperialbrc.nihr.ac.uk/research/infection/covid-19/covid-19-ongoing-studies/oncovid/,Disease specific network (cohort study),No,NI,"Other: World-Wide (UK, Spain, Switzerland, Russia, South Korea, Philippines, ...)",ESMO-CoCARE,https://www.esmo.org/covid-19-and-cancer/registries-studies-and-surveys/esmo-cocare-registry,Hospital data (electronic health record); Disease specific network (cohort study),No,NI,"","","","","","","","","","","",""
169,Wilshire 2022,Comparing Initial Surgery versus Fibrinolytics for Pleural Space Infections: A Retrospective Multicenter Cohort Study.,Consensus,#169 – Wilshire 2022,Comparing Initial Surgery versus Fibrinolytics for Pleural Space Infections: A Retrospective Multicenter Cohort Study.,01.11.2022,"Jed A. Gorden, M.D., Division of Thoracic Surgery and Interventional
Pulmonology, Swedish Cancer Institute, 1101 Madison Street, Suite 900, Seattle, WA 98104. E-mail: jed.gorden@swedish.org.",https://doi.org/10.1513/AnnalsATS.202108-964OC,"",1,USA,Providence-Swedish healthcare system ,NI,Insurance/claims data (prescription data),No,Yes,"","","","","","","","","","","","","","","","","",""
166,Johnson 2022,Association of Reduced Hospitalizations and Mortality Rates Among COVID-19-Vaccinated Patients With Heart Failure.,Consensus,#166 – Johnson 2022,Association of Reduced Hospitalizations and Mortality Rates Among COVID-19-Vaccinated Patients With Heart Failure.,09.06.2022,"Anuradha Lala, MD, Mount Sinai Medical
Center: Mount Sinai Health System. 1 Gustave Levy Pl. New York,",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178679/,"",1,USA,Mount Sinai Health System,https://labs.icahn.mssm.edu/msdw/ (not currently working),Hospital data (electronic health record),NI,NI,"","","","","","","","","","","","","","","","","",""
165,Pinato 2022,"Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.",Consensus,#165 – Pinato 2022,"Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.",23.05.2022,"alessiocortellini@gmail.com, a.cortellini@imperial.ac.uk (A. Cortellini)",https://doi.org/10.1016/j.ejca.2022.04.036,"",1,"",OnCovid,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
163,Wu 2022,The Impact of COVID-19 on Postdischarge Outcomes for Dialysis Patients in the United States: Evidence from Medicare Claims Data.,Consensus,#163 – Wu 2022,The Impact of COVID-19 on Postdischarge Outcomes for Dialysis Patients in the United States: Evidence from Medicare Claims Data,30.06.2022," Dr. John D. Kalbfleisch, Kidney Epidemiology and Cost Center, University of Michigan, 1415 Washington Heights,
Suite 3645A SPH I, Ann Arbor, MI 48109. Email: jdkalbfl@umich.edu",https://doi.org/10.34067/KID.0000242022,"",1,USA,Medicare,NI,Insurance/claims data (prescription data),No,Yes,"","","","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","",""
162,Bowe 2022,Acute and postacute sequelae associated with SARS-CoV-2 reinfection.,Consensus,#162 – Bowe 2022,Acute and postacute sequelae associated with SARS-CoV-2 reinfection.,10.11.2022,"Ziyad Al-Aly, Veterans Research and Education Foundation of St. Louis, St. Louis, MO, USA, zalaly@gmail.com",https://www.nature.com/articles/s41591-022-02051-3,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system",https://www.data.va.gov/,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
159,Mues 2022,Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States.,Consensus,#159 – Mues 2022,Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States.,24.09.2022,"Aetion, Inc, 5 Pennsylvania Plaza, New York, NY 10001, USA
E-mail address: katie.mues@aetion.com (K.E. Mues)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507810/,"",1,USA,HealthVerity,https://healthverity.com/mastersets/covid-19/,Insurance/claims data (prescription data),No,NI,"","","","","","","","","","","","","","","","","",""
147,Xu 2022,Long-term neurologic outcomes of COVID-19.,Consensus,#147 – Xu 2022,Long-term neurologic outcomes of COVID-19,22.09.2022,"Z Al-Aly VA Saint Louis Health Care System, Saint Louis, MO 63106, USA zalaly@gmail.com (or @zalaly on Twitter)",https://www.nature.com/articles/s41591-022-02001-z,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
140,Langer-Gould 2023,Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness.,Consensus,#140 – Langer-Gould 2023,Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness.,18.11.2022,"Annette Langer-Gould, Southern California Permanente Medical Group, Neurology Department, Los Angeles Medical Center, 1505 N Edgemont, 5th Floor, Los Angeles, CA 90027.",https://doi.org/10.1016/j.ijid.2022.11.017,"",2,USA,KPSC Research Data Warehouse,"","",Other: ,Other: ,USA,"KPNC Virtual Data Warehouse on exposures, outcomes, and covariates of interest","","",Other: ,Other: ,"","","","","","","","","","","",""
139,MohdKamil 2023,Non-rebreather mask and low-flow nasal cannula vs high-flow nasal cannula in severe COVID-19 pneumonia in the emergency department.,Consensus,#139 – MohdKamil 2023,Non-rebreather mask and low-flow nasal cannula vs high-flow nasal cannula in severe COVID-19 pneumonia in the emergency department.,19.10.2022,"E-mail addresses: presisoc90@gmail.com (M.K. Mohd Kamil),
khadijah.poh@ummc.edu.my (K.P. Yuen Yoong), muhaimin@um.edu.my
(A.M. Noor Azhar), aidabustam@um.edu.my (A. Bustam), hafyzuddin@ummc.edu.my (M.H. Md Yusuf), nuraliyah@ummc.edu.my (A. Zambri), ahmadzulkarnain@ummc.edu.my (A.Z. Ahmad Zahedi).",https://doi.org/10.1016/j.ajem.2022.10.029,"Retrospective, two hospitals. Useless.",1,Other: Malaysia,NI,NI,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
131,Shimizu 2023,Early physical rehabilitation effectiveness in frail older patients hospitalized for community-acquired pneumonia: analysis of a nationwide database in Japan.,Consensus,#131 – Shimizu 2023,Early physical rehabilitation effectiveness in frail older patients hospitalized for community-acquired pneumonia: analysis of a nationwide database in Japan.,14.11.2022,"Akio Shimizu 
a.shimizu.diet@gmail.com",https://pubmed.ncbi.nlm.nih.gov/36376622/,"",1,Japan,Diagnosis Procedure Combination database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
129,Cao 2023,Bidirectional causal associations between type 2 diabetes and COVID-19.,Consensus,#129 – Cao 2023,Bidirectional causal associations between type 2 diabetes and COVID-19.,07.09.2022,"Fuquan Zhang, Department of Psychiatry, The
Affiliated Brain Hospital of Nanjing Medical
University, 264 Guangzhou Rd,
Nanjing 210029, China.
Email: zhangfq@njmu.edu.cn",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538258/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
127,Kimura 2023,Association Between Systemic Corticosteroid Use and Mortality in Patients with Epiglottitis.,Consensus,#127 – Kimura 2023,"Association Between Systemic Corticosteroid Use and Mortality in
Patients with Epiglottitis",19.03.2022,"Yuya Kimura, MD, Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-shi, Tokyo 204-8585, Japan.

Email: yuk.close.to.wrd.34@gmail.com",https://doi.org/10.1002/lary.30110,"",1,Japan,Diagnosis Procedure Combination database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
126,Moromizato 2023,Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study.,Consensus,#126 – Moromizato 2023,Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study,08.02.2023,"Yasuharu Tokuda
yasuharu.tokuda@gmail.com",https://pubmed.ncbi.nlm.nih.gov/36755340/,"",1,Japan,Diagnosis Procedure Combination database,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
122,Ni 2023,Shared genetic architecture between type 2 diabetes and COVID-19 severity.,Consensus,#122 – Ni 2023,Shared genetic architecture between type 2 diabetes and COVID-19 severity.,21.09.2022,"H-F. Pan, panhaifeng@ahmu.edu.cn",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489484/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
121,Portmann 2023,Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.,Consensus,#121 – Portmann 2023,Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.,15.02.2023,"Rami Sommerstein, MD, Department of Health Sciences and Medicine, Clinic St Anna, University of Lucerne, Switzerland (rami.sommerstein@unilu.ch).",https://pubmed.ncbi.nlm.nih.gov/36790812/,"",1,Other: Switzerland,Hospital-based surveillance of COVID-19 in Switzerland,https://www.unige.ch/medecine/hospital-covid/,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
117,Liu 2023,Association between trans fatty acids and COVID-19: A multivariate Mendelian randomization study.,Consensus,#117 – Liu 2023,Association between trans fatty acids and COVID-19: A multivariate Mendelian randomization study.,04.01.2023,"Dongbo Xue, Chenjun Hao and Yingmei
Zhang, Key Laboratory of Hepatosplenic
Surgery, Ministry of Education, The First
Affiliated Hospital of Harbin Medical
University, Harbin, China.
Email: xuedongbo@hrbmu.edu.cn;
haochenjun@hrbmu.edu.cn and
zhangyingmei@hrbmu.edu.cn",https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.28455,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
116,Xu 2023,Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.,Consensus,#116 – Xu 2023,Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.,06.01.2023,"Z Al-Aly VA Saint Louis Health Care System, Saint Louis, MO 63106, USA zalaly@gmail.com (or @zalaly on Twitter)",https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00355-2/fulltext,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
114,Djulbegovic 2023,Evaluation of a fast-and-frugal clinical decision algorithm ('pathways') on clinical outcomes in hospitalised patients with COVID-19 treated with anticoagulants.,Consensus,#114 – Djulbegovic 2023,Evaluation of a fast-and-frugal clinical decision algorithm ('pathways') on clinical outcomes in hospitalised patients with COVID-19 treated with anticoagulants.,13.10.2022,"Benjamin Djulbegovic, MD, PhD, Beckman Research Institute, 1500 E Duarte Rd, Duarte, CA 91010-3000, USA.

bdjulbegovic@coh.org",https://doi.org/10.1111/jep.13780,"",1,USA,Rush University Hospital Data Warehouse,https://www.rushu.rush.edu/research/resources-researchers/data-management,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
112,Hamilton 2023,Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study.,Consensus,#112 – Hamilton 2023,Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study.,30.01.2023,"Fergus Hamilton, fergus.hamilton@bristol.ac.uk",https://doi.org/10.1371/journal.pmed.1004174,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","",Other: ,Other: 
111,D'Andrea 2023,Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study.,Consensus,#111 – D'Andrea 2023,Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study.,18.02.2023,"Giale Giacobazzi, 96, 41049 Sassuolo (MO), Italy. 
E-mail address: giuseppe.dandrea6@studio.unibo.it (G. D'Andrea).",https://doi.org/10.1016/j.jpsychores.2023.111199,"",1,Other: Italy,PREDI-CO,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
99,Xie 2023,Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records.,Consensus,#99 – Xie 2023,Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records.,11.04.2023,"Z Al-Aly
zalaly@gmail.com 
(or @zalaly on Twitter; 
ORCID 0000-0002-2600-0434)",https://doi.org/10.1136/bmj-2022-073312,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
97,Zhang 2022,Application of Causal Discovery Algorithms in Studying the Nephrotoxicity of Remdesivir Using Longitudinal Data from the EHR.,Consensus,#97 – Zhang 2022,Application of Causal Discovery Algorithms in Studying the Nephrotoxicity of Remdesivir Using Longitudinal Data from the EHR.,29.04.2023,https://www.linkedin.com/in/jianqiu-zhang-6b135a118/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148284/,"",1,USA,University of Minnesota Clinical and Translational Institute (CTSI) data repository,https://ctsi.umn.edu/services/data-informatics/find-access-data,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
94,Ambrose 2023,Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes.,Consensus,#94 – Ambrose 2023,Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes.,24.04.2023,"Brian Anderson, MD, The MITRE Corporation, 202 Burlington Rd, Mailstop E135, Bedford, MA 01730 (briananderson@mitre.org).",https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2803990,NI. ,1,USA,NI,NI,Other: Outpatient,No,NI,"","","","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","",Other: ,Other: 
93,Xie 2023,Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.,Consensus,#93 – Xie 2023,Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.,25.04.2023,"Z Al-Aly VA Saint Louis Health Care System, Saint Louis, MO 63106, USA zalaly@gmail.com (or @zalaly on Twitter)",https://doi.org/10.1136/bmj-2022-074572,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
91,Jones 2023,Incidence and Outcomes of Non-Ventilator-Associated Hospital-Acquired Pneumonia in 284 US Hospitals Using Electronic Surveillance Criteria.,Consensus,#91 – Jones 2023,Incidence and Outcomes of Non-Ventilator-Associated Hospital-Acquired Pneumonia in 284 US Hospitals Using Electronic Surveillance Criteria.,18.05.2023,"Barbara E. Jones, MD, MS, University of Utah School of Medicine, 50 N Medical Dr, 701 Wintrobe, Salt Lake City, UT 84103 (ude.hatu.csh@senoj.arabraB).",https://pubmed.ncbi.nlm.nih.gov/37200031/,"",2,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,USA,Harvard Pilgrim Health Care Institute (HCA Healthcare Networks),NI,Hospital data (electronic health record),NI,NI,"","","","","","","","","","","",""
90,Bugiardini 2023,Sex differences and disparities in cardiovascular outcomes of COVID-19.,Consensus,#90 – Bugiardini 2023,Sex differences and disparities in cardiovascular outcomes of COVID-19.,18.01.2023,"Department of Medical and Surgical Sciences, University of Bologna, Padiglione 11, Via Massarenti 9, 40138 Bologna, Italy
Corresponding author. Tel: +39 051347290; fax: +39 051347290, E-mail: raffaele.bugiardini@unibo.it",https://pubmed.ncbi.nlm.nih.gov/36651866/,"",1,Other: Europe,ISACS-COVID-19,https://clinicaltrials.gov/study/NCT05188612,Hospital data (electronic health record),No,NI,"","","","","","","","","","","","","","","","","",""
87,Wai 2023,Association of Molnupiravir and Nirmatrelvir-Ritonavir with reduced mortality and sepsis in hospitalized omicron patients: a territory-wide study.,Consensus,#87 – Wai 2023,Association of Molnupiravir and Nirmatrelvir-Ritonavir with reduced mortality and sepsis in hospitalized omicron patients: a territory-wide study,15.03.2023,"Timothy Hudson Rainer, thrainer@hku.hk",https://pubmed.ncbi.nlm.nih.gov/37188726/,"""CDARS data is not accurate enough for clinical audit..:"" https://www3.ha.org.hk/haconvention/hac2007proceedings/pdf/spp5_2_tlkwan.pdf",1,Other: Hong Kong,"Clinical 
Data Analysis and Reporting System (CDARS)",NI,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
86,Xu 2023,No genetic causal association between systemic lupus erythematosus and COVID-19.,Consensus,#86 – Xu 2023,No genetic causal association between systemic lupus erythematosus and COVID-19.,18.05.2023,"Sha-Sha Tao
taoshasha1212@126.com
Zong-Wen Shuai
shuaizongwen@ahmu.edu.cn",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232808/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
85,Ohl 2023,Mortality Among US Veterans Admitted to Community vs Veterans Health Administration Hospitals for COVID-19.,Consensus,#85 – Ohl 2023,Mortality Among US Veterans Admitted to Community vs Veterans Health Administration Hospitals for COVID-19.,30.05.2023,"Michael E. Ohl, MD, MSPH, Veterans Rural Health Resource Center–Iowa City, Iowa City Veterans Affairs Health Care System, 601 Highway 6 W, Bldg 42, Iowa City, IA 52246 (michael-ohl@uiowa.edu).",https://pubmed.ncbi.nlm.nih.gov/37252740/,"",1,USA,"Department of Veterans Health
Administration (VHA) healthcare system","","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
79,Leding 2023,Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone.,Consensus,#79 – Leding 2023,Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone.,11.03.2023,"Cæcilie Leding, caecilie.leding@regionh.dk, Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital – Amager and Hvidovre, Kettegaard Alle 30, Hvidovre, 2650, Denmark",https://pubmed.ncbi.nlm.nih.gov/36905638/,"",1,Denmark,NI,NI,"Hospital data (electronic health record); National registries (e.g. death registry, cancer registry, etc.)",NI,NI,"","","","","","","","","","","","","","","","","",""
75,Chemaitelly 2023,Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study.,Consensus,#75 – Chemaitelly 2023,Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study.,10.03.2023,"Dr Hiam Chemaitelly, Infectious 
Disease Epidemiology Group, 
Weill Cornell Medicine-Qatar, 
Doha 24144, Qatar
hsc2001@qatar-med.cornell.
edu",https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00058-0/fulltext,"",1,Other: Qatar,Qatar Cerner-system advanced,NI,"Hospital data (electronic health record); National registries (e.g. death registry, cancer registry, etc.)",No,Yes,"","","","","","","","","","","","","","","","","",""
74,Chan 2022,Metformin is associated with reduced COVID-19 severity in patients with prediabetes.,Consensus,#74 – Chan 2022,Metformin is associated with reduced COVID-19 severity in patients with prediabetes.,15.11.2022,"Lawrence Berkeley National Laboratory, 717 Potter St., Berkeley, CA 94710, USA. E-mail address: justinreese@lbl.gov",https://doi.org/10.1016/j.diabres.2022.110157,Currently setting up an extension.,1,USA,National COVID Cohort Collaborative (N3C),"https://covid.cd2h.org/

Data dictionary: https://ncats.nih.gov/sites/default/files/OMOP_CDM_COVID.pdf",Hospital data (electronic health record); Disease specific network (cohort study),No,Yes,"","","","","","","","","","","","","","","","","",""
68,Tagliamento 2023,Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.,Consensus,#68 – Tagliamento 2023,Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.,31.01.2023,"Alessio Cortellini, MD, PhD, Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, United Kingdom; e-mail: alessiocortellini@gmail.com.",https://pubmed.ncbi.nlm.nih.gov/36720089/,"",1,"",OnCovid,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
65,Breskin 2023,Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation.,Consensus,#65 – Breskin 2023,Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation.,01.05.2023,"Correspondence: M. W. Fried, TARGET PharmaSolutions, Inc., 2520 Meridian Pkwy, Suite 105, Durham, NC 27713 (mfried@targetpharmasolutions.com).",https://academic.oup.com/cid/article/72/10/e558/5898276?login=false,"",1,USA,NI,NI,Insurance/claims data (prescription data),No,NI,"","","","","","","","","","","","","","","","","",""
63,Langer-Gould 2022,High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness.,Consensus,#63 – Langer-Gould 2022,High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness.,29.10.2022,"Annette Langer-Gould, Southern California Permanente Medical Group, Neurology Department, Los Angeles Medical Center, 1505 N Edgemont, 5th Floor, Los Angeles, CA 90027",https://doi.org/10.1016/j.ijid.2022.10.023,"",2,USA,KPSC Research Data Warehouse,https://www.kp-scalresearch.org/aboutus/resources-capabilities/information-and-data-resources/,Hospital data (electronic health record),No,Yes,USA,"KPNC Virtual Data Warehouse on exposures, outcomes, and covariates of interest",NI,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","",""
57,Rivera 2023,Association of statin use with outcomes of patients admitted with COVID-19: an analysis of electronic health records using superlearner.,Consensus,#57 – Rivera 2023,Association of statin use with outcomes of patients admitted with COVID-19: an analysis of electronic health records using superlearner.,24.02.2023,"Babafemi Taiwo, b-taiwo@northwestern.edu",https://doi.org/10.1186/s12879-023-08026-0,"",1,USA,"Northwestern Medicine Electronic Data 
Warehouse (NMEDW) ",https://www.feinberg.northwestern.edu/research/cores/units/edw.html,Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
49,Butler-Laporte 2023,Increasing serum iron levels and their role in the risk of infectious diseases: a Mendelian randomization approach.,Consensus,#49 – Butler-Laporte 2023,Increasing serum iron levels and their role in the risk of infectious diseases: a Mendelian randomization approach.,11.02.2023,"Corresponding author. Lady Davis Institute for Medical Research, Jewish General Hospital, Pavilion H-413, 3755 Coˆte-
Ste-Catherine, Montre´ al, QC H3T 1E2, Canada. E-mail: brent.richards@mcgill.ca",https://doi.org/10.1093/ije/dyad010,"Canadian Long Study is outpatient only, so I excluded it.",2,Other: Netherlands,Amsterdam UMC,[Reuse of health care data for scientific research (amsterdamumc.org)](https://www.amsterdamumc.org/en/research/support/services-facilities/data-management/reuse-of-health-care-data-for-scientific-research.htm),Hospital data (electronic health record),No,Yes,USA,UCLA,[Design Study | ResearchGo | UCLA](https://www.researchgo.ucla.edu/design-study),Hospital data (electronic health record),No,Yes,"","","","",Other: ,Other: ,"","","","",Other: ,Other: 
48,Myers 2023,The impact of timing of initiating invasive mechanical ventilation in COVID-19-related respiratory failure.,Consensus,#48 – Myers 2023,The impact of timing of initiating invasive mechanical ventilation in COVID-19-related respiratory failure.,08.05.2023,"Kaiser Permanente Northern California Division of Research, 2000 Broadway, Oakland, CA 94612, United States of America. E-mail address: laura.c.myers@kp.org (L.C. Myers)",https://doi.org/10.1016/j.jcrc.2023.154322,"",2,USA,KPSC Research Data Warehouse,"","",Other: ,Other: ,USA,"KPNC Virtual Data Warehouse on exposures, outcomes, and covariates of interest","","",Other: ,Other: ,"","","","","","","","","","","",""
38,Long 2023,The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study.,Consensus,#38 – Long 2023,The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study.,18.08.2023,"Xia Jiang
xiajiang@scu.edu.cn
Chuanwen Fan
chuanwen.fan@liu.se
Ben Zhang
ben.zhang@scu.edu.cn",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472139/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","",Other: ,Other: 
37,Labor 2023,Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD.,Consensus,#37 – Labor 2023,Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD,07.08.2023,"Marina Labor, Cancer and Lung Health Care Unit, University Hospital in Linköping, Linköping, Sweden, Tel +46739238935
Email marina.os21@gmail.com",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421743/,"",1,Other: Sweden,Swedish COVID-19 Investigation for Future Insights,"https://www.gu.se/en/research/scifi-pearl

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331198/","National registries (e.g. death registry, cancer registry, etc.); Other: Outpatient",No,NI,"","","","","","","","","","","","","","","","","",""
28,Cao 2023,Causal associations and genetic overlap between COVID-19 and intelligence.,Consensus,#28 – Cao 2023,Causal associations and genetic overlap between COVID-19 and intelligence.,07.06.2023," Fuquan Zhang, Department of Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University, 264 Guangzhou Road, Nanjing
210029, China. email: zhangfq@njmu.edu.cn",https://doi.org/10.1093/qjmed/hcad122,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
27,Wang 2023,GDF-15 (a biomarker for metformin) and the risk of COVID-19: A two-sample Mendelian randomization study.,Consensus,#27 – Wang 2023,GDF-15 (a biomarker for metformin) and the risk of COVID-19: A two-sample Mendelian randomization study.,29.09.2023,"Shanyu Qin, Gastroenterology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, China (e-mail: qinshanyu@gxmu.edu.cn).",https://pubmed.ncbi.nlm.nih.gov/37773870/,"This paper is a meta-analysis. The original data set is in another paper. ""Sourced from a study by Au Yeung SL et al (PMID: 31161347)"" which paper used: the UK Biobank, Framingham Offspring Cohort, the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study, the Northern Sweden Population Health Study (NSPHS), and the Sydney Memory and Ageing Study (Sydney MAS), CARDIoGRAMplusC4D 1000 Genomes-based GWAS, DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, deCODE, Centre d’Etude du Polymorphisme Humain (CEPH), Global Lipids Genetics Consortium (GLGC), Genetic Traits (GIANT) Consortium, Breast Cancer Association Consortium (BCAC), SAIGE UK Biobank. Who's calling all these people? ;)",1,"",Covid HGI,"","",Other: ,Other: ,"","","","","","","","","","","","","","","","","",""
22,Lu 2023,No causal association between COVID-19 and sepsis: a bidirectional two-sample Mendelian randomization study.,Consensus,#22 – Lu 2023,No causal association between COVID-19 and sepsis: a bidirectional two-sample Mendelian randomization study.,09.10.2023,"Ming Zhong
zhongming_oral@aliyun.com",https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1183489/full,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
18,Endo 2023,Association between Legionella urinary antigen tests on admission and inhospital mortality in patients with atypical pneumonia: A nationwide database study.,Consensus,#18 – Endo 2023,Association between Legionella urinary antigen tests on admission and inhospital mortality in patients with atypical pneumonia: A nationwide database study.,15.07.2023,"Masayuki Endo, Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: emasayuki@m.u-tokyo.ac.jp",https://journals.lww.com/ijmy/fulltext/2023/12030/association_between_legionella_urinary_antigen.20.aspx,"",1,Japan,Diagnosis Procedure Combination database,"https://www.jstage.jst.go.jp/article/ace/1/3/1_76/_pdf#:~:text=The%20Diagnosis%20Procedure%20Combination%20(DPC,system%20(DPC%2F%20PDPS).",Hospital data (electronic health record),No,Yes,"","","","","","","","","","","","","","","","","",""
16,Pan 2023,Genetic Predisposition to Elevated Levels of Circulating ADAM17 Is Associated with the Risk of Severe COVID-19.,Consensus,#16 – Pan 2023,Genetic Predisposition to Elevated Levels of Circulating ADAM17 Is Associated with the Risk of Severe COVID-19.,01.11.2023,"Jiangming Sun, jiangming.sun@med.lu.se; Tel.: +46-(0)40-331403",https://pubmed.ncbi.nlm.nih.gov/37958866/,"",1,"",Covid HGI,"","",Other: ,Other: ,"","","","",Other: ,Other: ,"","","","","","","","","","","",""
6,Lee 2023,Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study.,Consensus,#6 – Lee 2023,Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study,20.10.2023,"Sun‑Young Jung - jsyoung@cau.ac.kr, Won‑Young Kim - wykim81@cau.ac.k",https://doi.org/10.1186/s12916-023-03106-z,"",1,South Korea,Korean National Health Insurance Service (NHIS) database,NI,Insurance/claims data (prescription data),No,Yes,"","","","","","","","","","","","","","","","","",""
